Advertisement

Glycoconjugate Journal

, Volume 29, Issue 4, pp 211–220 | Cite as

Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus

  • Fumi Kobayashi
  • Shuhei YamadaEmail author
  • Shuhei Taguwa
  • Chikako Kataoka
  • Satomi Naito
  • Yoshiki Hama
  • Hideki Tani
  • Yoshiharu Matsuura
  • Kazuyuki SugaharaEmail author
Article

Abstract

The first step in the process of infections by the hepatitis C virus (HCV) is attachment to the host cell, which is assumed to be mediated by interaction of the envelope glycoproteins E1 and E2 with cell surface glycosaminoglycans. In this study, a variety of glycosaminoglycans, heparan sulfate (HS) from various bovine tissues as well as chondroitin sulfate (CS)/dermatan sulfate from bovine liver, were used to examine the direct interaction with recombinant E1 and E2 proteins. Intriguingly, among HS preparations from various bovine tissues, only liver HS strongly bound to both E1 and E2. Since HS from liver, which is the target tissue of HCV, contains highly sulfated structures compared to HS from other tissues, the present results suggest that HS-proteoglycan on the liver cell surface appears to be one of the molecules that define the liver-specific tissue tropism of HCV infection. The interaction assay with chemically modified heparin derivatives provided evidence that the binding of the viral proteins to heparin/HS is not only mediated by simple ionic interactions, but that the 6-O-sulfation and N-sulfation are important. Heparin oligosaccharides equal to or larger than 10-mer were required to inhibit the binding. Notably, a highly sulfated CS-E preparation from squid cartilage also strongly interacted with both viral proteins and inhibited the entry of pseudotype HCV into the target cells, suggesting that the highly sulfated CS-E might be useful as an anti-HCV drug.

Keywords

Heparan sulfate Chondroitin sulfate Hepatitis C virus Glycosaminoglycan Tissue tropism 

Abbreviations

2AB

2-aminobenzamide

CDNA

completely desulfated and N-acetylated heparin

CDNS

completely desulfated and N-sulfated heparin

NDNA

N-desulfated and N-acetylated heparin

2ODS

2-O-desulfated heparin

6ODS

6-O-desulfated heparin

CS

chondroitin sulfate

DS

dermatan sulfate

ELISA

enzyme-linked immunosorbent assay

FGF

fibroblast growth factor

GAG

glycosaminoglycan

HCV

hepatitis C virus

ΔHexA

4-deoxy-α-L-threo-hex-4-enepyranosyluronic acid

HPLC

high performance liquid chromatography

HS

heparan sulfate

PG

proteoglycan

VSV

vesicular stomatitis virus

NS

2-N-sulfate

2S

2-O-sulfate

4S

4-O-sulfate

6S

6-O-sulfate

Notes

Acknowledgments

The authors thank Satoko Ueno, Naoko Shoji, and Machiko Tomimatsu for technical assistance. This work was supported in part by Grants-in-aid for Scientific Research C-21590057 (to S. Y.), Scientific Research (B) 23390016 (to K. S.), and the Matching Program for Innovations in Future Drug Discovery and Medical Care (to K. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT).

Supplementary material

10719_2012_9388_MOESM1_ESM.pdf (296 kb)
Supplementary Data 1 (PDF 296 kb)
10719_2012_9388_MOESM2_ESM.pdf (130 kb)
Supplementary Data 2 (PDF 130 kb)

References

  1. 1.
    Wasley, A., Alter, M.J.: Epidemiology of hepatitis C: geographic differences and temporal trends. Semin. Liver Dis. 20, 1–16 (2000)PubMedCrossRefGoogle Scholar
  2. 2.
    Lauer, G.M., Walker, B.D.: Hepatitis C virus infection. N. Engl. J. Med. 345, 41–52 (2001)PubMedCrossRefGoogle Scholar
  3. 3.
    Barth, H., Schafer, C., Adah, M.I., Zhang, F., Linhardt, R.J., Toyoda, H., Kinoshita-Toyoda, A., Toida, T., Van Kuppevelt, T.H., Depla, E., Von Weizsacker, F., Blum, H.E., Baumert, T.F.: Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 278, 41003–41012 (2003)PubMedCrossRefGoogle Scholar
  4. 4.
    Koutsoudakis, G., Kaul, A., Steinmann, E., Kallis, S., Lohmann, V., Pietschmann, T., Bartenschlager, R.: Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 80, 5308–5320 (2006)PubMedCrossRefGoogle Scholar
  5. 5.
    Agnello, V., Abel, G., Elfahal, M., Knight, G.B., Zhang, Q.X.: Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc. Natl. Acad. Sci. U. S. A. 96, 12766–12771 (1999)PubMedCrossRefGoogle Scholar
  6. 6.
    Monazahian, M., Böhme, I., Bonk, S., Koch, A., Scholz, C., Grethe, S., Thomssen, R.: Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 57, 223–229 (1999)PubMedCrossRefGoogle Scholar
  7. 7.
    Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A.J., Houghton, M., Rosa, D., Grandi, G., Abrignani, S.: Binding of hepatitis C virus to CD81. Science 282, 938–941 (1998)PubMedCrossRefGoogle Scholar
  8. 8.
    Bartosch, B., Vitelli, A., Granier, C., Goujon, C., Dubuisson, J., Pascale, S., Scarselli, E., Cortese, R., Nicosia, A., Cosset, F.L.: Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 278, 41624–41630 (2003)PubMedCrossRefGoogle Scholar
  9. 9.
    Evans, M.J., von Hahn, T., Tscherne, D.M., Syder, A.J., Panis, M., Wölk, B., Hatziioannou, T., McKeating, J.A., Bieniasz, P.D., Rice, C.M.: Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446, 801–805 (2007)PubMedCrossRefGoogle Scholar
  10. 10.
    Liu, S., Yang, W., Shen, L., Turner, J.R., Coyne, C.B., Wang, T.: Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J. Virol. 83, 2011–2014 (2009)PubMedCrossRefGoogle Scholar
  11. 11.
    Moradpour, D., Penin, F., Rice, C.M.: Replication of hepatitis C virus. Nat. Rev. Microbiol. 5, 453–463 (2007)PubMedCrossRefGoogle Scholar
  12. 12.
    Garson, J.A., Lubach, D., Passas, J., Whitby, K., Grant, P.R.: Suramin blocks hepatitis C binding to human hepatoma cells in vitro. J. Med. Virol. 57, 238–242 (1999)PubMedCrossRefGoogle Scholar
  13. 13.
    Liu, B., Paranjpe, S., Bowen, W.C., Bell, A.W., Luo, J.H., Yu, Y.P., Mars, W.M., Michalopoulos, G.K.: Investigation of the role of glypican 3 in liver regeneration and hepatocyte proliferation. Am. J. Pathol. 175, 717–724 (2009)PubMedCrossRefGoogle Scholar
  14. 14.
    Yagnik, A.T., Lahm, A., Meola, A., Roccasecca, R.M., Ercole, B.B., Nicosia, A., Tramontano, A.: A model for the hepatitis C virus envelope glycoprotein E2. Proteins 40, 355–366 (2000)PubMedCrossRefGoogle Scholar
  15. 15.
    Sugahara, K., Kitagawa, H.: Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans. Curr. Opin. Struct. Biol. 10, 518–527 (2000)PubMedCrossRefGoogle Scholar
  16. 16.
    Esko, J.D., Selleck, S.B.: Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71, 435–471 (2001)PubMedCrossRefGoogle Scholar
  17. 17.
    Yamada, S., Sugahara, K.: Potential therapeutic application of chondroitin sulfate/dermatan sulfate. Curr. Drug Discov. Tech. 5, 289–301 (2008)CrossRefGoogle Scholar
  18. 18.
    Casu, B., Lindahl, U.: Structure and biological interactions of heparin and heparan sulfate. Adv. Carbohydr. Chem. Biochem. 57, 159–206 (2001)PubMedCrossRefGoogle Scholar
  19. 19.
    Kreuger, J., Spillmann, D., Li, J.P., Lindahl, U.: Interactions between heparan sulfate and proteins: the concept of specificity. J. Cell Biol. 174, 323–327 (2006)PubMedCrossRefGoogle Scholar
  20. 20.
    Shukla, D., Spear, P.G.: Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Invest. 108, 503–510 (2001)PubMedGoogle Scholar
  21. 21.
    Spillmann, D.: Heparan sulfate: anchor for viral intruders? Biochimie 83, 811–817 (2001)PubMedCrossRefGoogle Scholar
  22. 22.
    Rostand, K.S., Esko, J.D.: Microbial adherence to and invasion through proteoglycans. Infect. Immun. 65, 1–8 (1997)PubMedGoogle Scholar
  23. 23.
    Giroglou, T., Florin, L., Schäfer, F., Streeck, R.E., Sapp, M.: Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 75, 1565–1570 (2001)PubMedCrossRefGoogle Scholar
  24. 24.
    Birkmann, A., Mahr, K., Ensser, A., Yağuboğlu, S., Titgemeyer, F., Fleckenstein, B., Neipel, F.: Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J. Virol. 75, 11583–11593 (2001)PubMedCrossRefGoogle Scholar
  25. 25.
    Liu, J., Thorp, S.C.: Cell surface heparan sulfate and its roles in assisting viral infections. Med. Res. Rev. 22, 1–25 (2002)PubMedCrossRefGoogle Scholar
  26. 26.
    Ishihara, M., Takano, R., Kanda, T., Hayashi, K., Hara, S., Kikuchi, H., Yoshida, K.: Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2. J. Biochem. 118, 1255–1260 (1995)PubMedGoogle Scholar
  27. 27.
    Ishihara, M., Kariya, Y., Kikuchi, H., Minamisawa, T., Yoshida, K.: Importance of 2-O-sulfate groups of uronate residues in heparin for activation of FGF-1 and FGF-2. J. Biochem. 121, 345–349 (1997)PubMedCrossRefGoogle Scholar
  28. 28.
    Maccarana, M., Sakura, Y., Tawada, A., Yoshida, K., Lindahl, U.: Domain structure of heparan sulfates from bovine organs. J. Biol. Chem. 271, 17804–17810 (1996)PubMedCrossRefGoogle Scholar
  29. 29.
    Yamane, Y., Tohno-oka, R., Yamada, S., Furuya, S., Shiokawa, K., Hirabayashi, Y., Sugino, H., Sugahara, K.: Molecular characterization of Xenopus embryo heparan sulfate. Differential structural requirements for the specific binding to basic fibroblast growth factor and follistatin. J. Biol. Chem. 273, 7375–7381 (1998)PubMedCrossRefGoogle Scholar
  30. 30.
    Ueno, M., Yamada, S., Zako, M., Bernfield, M., Sugahara, K.: Structural characterization of heparan sulfate and chondroitin sulfate of syndecan-1 purified from normal murine mammary gland epithelial cells. Common phosphorylation of xylose and differential sulfation of galactose in the protein linkage region tetrasaccharide sequence. J. Biol. Chem. 276, 29134–29140 (2001)PubMedCrossRefGoogle Scholar
  31. 31.
    Nandini, C.D., Itoh, N., Sugahara, K.: Novel 70-kDa chondroitin sulfate/dermatan sulfate hybrid chains with a unique heterogeneous sulfation pattern from shark skin, which exhibit neuritogenic activity and binding activities for growth factors and neurotrophic factors. J. Biol. Chem. 280, 4058–4069 (2005)PubMedCrossRefGoogle Scholar
  32. 32.
    Kinoshita, A., Sugahara, K.: Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with the fluorophore 2-aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exo-sequencing of oligosaccharides. Anal. Biochem. 269, 367–378 (1999)PubMedCrossRefGoogle Scholar
  33. 33.
    Kawashima, H., Atarashi, K., Hirose, M., Hirose, J., Yamada, S., Sugahara, K., Miyasaka, M.: Oversulfated chondroitin/dermatan sulfates containing GlcAβ1/IdoAα1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J. Biol. Chem. 277, 12921–12930 (2002)PubMedCrossRefGoogle Scholar
  34. 34.
    Saito, A., Munakata, H., Satoh, K.: Glyco-western blotting: biotinylated dermatan sulfate as a probe for the detection of dermatan sulfate binding proteins using western blotting. Connect. Tissue Res. 43, 1–7 (2002)PubMedGoogle Scholar
  35. 35.
    Tani, H., Komoda, Y., Matsuo, E., Suzuki, K., Hamamoto, I., Yamashita, T., Moriishi, K., Fujiyama, K., Kanto, T., Hayashi, N., Owsianka, A., Patel, A.H., Whitt, M.A., Matsuura, Y.: Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins. J. Virol. 81, 8601–8612 (2007)PubMedCrossRefGoogle Scholar
  36. 36.
    Vongchan, P., Warda, M., Toyoda, H., Toida, T., Marks, R.M., Linhardt, R.J.: Structural characterization of human liver heparan sulfate. Biochim. Biophys. Acta 1721, 1–8 (2005)PubMedCrossRefGoogle Scholar
  37. 37.
    Volpi, N.: Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis. Anal. Biochem. 273, 229–239 (1999)PubMedCrossRefGoogle Scholar
  38. 38.
    Volpi, N.: Hyaluronic acid and chondroitin sulfate unsaturated disaccharides analysis by high-performance liquid chromatography and fluorimetric detection with dansylhydrazine. Anal. Biochem. 277, 19–24 (2000)PubMedCrossRefGoogle Scholar
  39. 39.
    Matsuura, Y., Harada, S., Suzuki, R., Watanabe, Y., Inoue, Y., Saito, I., Miyamura, T.: Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells. J. Virol. 66, 1425–1431 (1992)PubMedGoogle Scholar
  40. 40.
    Barth, H., Schnober, E.K., Zhang, F., Linhardt, R.J., Depla, E., Boson, B., Cosset, F.L., Patel, A.H., Blum, H.E., Baumert, T.F.: Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J. Virol. 80, 10579–10590 (2006)PubMedCrossRefGoogle Scholar
  41. 41.
    Li, F., Yamada, S., Basappa, Shetty, A.K., Sugiura, M., Sugahara, K.: Determination of iduronic acid and glucuronic acid in sulfated chondroitin/dermatan hybrid chains by 1H-nuclear magnetic resonance spectroscopy. Glycoconj. J. 25, 603–610 (2008)PubMedCrossRefGoogle Scholar
  42. 42.
    Salmivirta, M., Lidholt, K., Lindahl, U.: Heparan sulfate: a piece of information. FASEB J. 10, 1270–1279 (1996)PubMedGoogle Scholar
  43. 43.
    Barth, H., Liang, T.J., Baumert, T.F.: Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44, 527–535 (2006)PubMedCrossRefGoogle Scholar
  44. 44.
    Yanagiya, A., Ohka, S., Hashida, N., Okamura, M., Taya, C., Kamoshita, N., Iwasaki, K., Sasaki, Y., Yonekawa, H., Nomoto, A.: Tissue-specific replicating capacity of a chimeric poliovirus that carries the internal ribosome entry site of hepatitis C virus in a new mouse model transgenic for the human poliovirus receptor. J. Virol. 77, 10479–10487 (2003)PubMedCrossRefGoogle Scholar
  45. 45.
    Bergström, T., Trybala, E., Spillmann, D.: Heparan sulfate and viral tropism. Nat. Med. 3, 1177 (1997)PubMedCrossRefGoogle Scholar
  46. 46.
    Dorner, M., Horwitz, J.A., Robbins, J.B., Barry, W.T., Feng, Q., Mu, K., Jones, C.T., Schoggins, J.W., Catanese, M.T., Burton, D.R., Law, M., Rice, C.M., Ploss, A.: A genetically humanized mouse model for hepatitis C virus infection. Nature 474, 208–211 (2011)PubMedCrossRefGoogle Scholar
  47. 47.
    Lyon, M., Deakin, J.A., Gallagher, J.T.: Liver heparan sulfate structure. A novel molecular design. J. Biol. Chem. 269, 11208–11215 (1994)PubMedGoogle Scholar
  48. 48.
    Krey, T., d’Alayer, J., Kikuti, C.M., Saulnier, A., Damier-Piolle, L., Petitpas, I., Johansson, D.X., Tawar, R.G., Baron, B., Robert, B., England, P., Persson, M.A., Martin, A., Rey, F.A.: The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS Pathog. 6, e1000762 (2010)PubMedCrossRefGoogle Scholar
  49. 49.
    Matsuura, Y., Tani, H., Suzuki, K., Kimura-Someya, T., Suzuki, R., Aizaki, H., Ishii, K., Moriishi, K., Robison, C.S., Whitt, M.A., Miyamura, T.: Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286, 263–275 (2001)PubMedCrossRefGoogle Scholar
  50. 50.
    Gospodarowicz, D., Cheng, J.: Heparin protects basic and acidic FGF from inactivation. J. Cell. Physiol. 128, 475–484 (1986)PubMedCrossRefGoogle Scholar
  51. 51.
    Powers, C.J., McLeskey, S.W., Wellstein, A.: Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Canc. 7, 165–197 (2000)CrossRefGoogle Scholar
  52. 52.
    Fernig, D.G., Gallagher, J.T.: Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Progr. Growth Factor Res. 5, 353–377 (1994)CrossRefGoogle Scholar
  53. 53.
    Mohammadi, M., Olsen, S.K., Goetz, R.: A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs. Curr. Opin. Struct. Biol. 15, 506–516 (2005)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Fumi Kobayashi
    • 1
  • Shuhei Yamada
    • 1
    • 2
    • 4
    Email author
  • Shuhei Taguwa
    • 3
  • Chikako Kataoka
    • 3
  • Satomi Naito
    • 2
  • Yoshiki Hama
    • 1
  • Hideki Tani
    • 3
  • Yoshiharu Matsuura
    • 3
  • Kazuyuki Sugahara
    • 1
    • 2
    Email author
  1. 1.Laboratory of Proteoglycan Signaling and TherapeuticsHokkaido University Graduate School of Life ScienceSapporoJapan
  2. 2.Department of BiochemistryKobe Pharmaceutical UniversityHigashinada-kuJapan
  3. 3.Department of Molecular Virology, Research Institute for Microbial DiseasesOsaka UniversitySuita-shiJapan
  4. 4.Department of Pathobiochemistry, Faculty of PharmacyMeijo UniversityTempaku-kuJapan

Personalised recommendations